Publications

2021

59. Pstras L, Stachowska-Pietka J, Debowska M, et al. Dialysis therapies: investigation of transport and regulatory process using mathematical modelling, BBE, 2021, accepted.

58. Deibel A, Deng L, Cheng CY, et al. Comparing efficacy and cost-efficiency of different colorectal cancer screening modalities using a microsimulation model, Gastrointestinal Endoscopy, 2021 Aug;94(2):379-390.e7. doi: 10.1016/j.gie.2021.02.013

57. Siwicka-Gieroba D, Robba C, Poleszczuk J, et al. Changes in sub-endocardial viability ratio in traumatic brain injury patients, Brain Connectivity, 2020, online first, doi.org/10.1089/brain.2020.0850.

56. Spalek MJ, Kosela-Paterczyk H, Borkowska A, et al. Combined preoperative hypofractionated radiotherapy with doxorubicin-ifosfamide chemotherapy in marginally resectable soft tissue sarcomas: results of a phase II clinical trial, International Journal of Radiation Oncology Biology Physics. 2021 Jul 15;110(4):1053-1063. doi: 10.1016/j.ijrobp.2021.02.019.

56. Jardim-Perassi BV, Mu W, Huang S, et al. Targeting hypoxic habitats with hypoxia pro-drug evofosfamide in preclinical models of sarcoma, Theranostics, 2021 Mar 11;11(11):5313-5329. doi: 10.7150/thno.56595. eCollection 2021

55. Spalek MJ, Poleszczuk J, Czarnecka AM, Radiotherapy in the Managment of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis, Cells. 2021 Feb 10;10(2):366. doi: 10.3390/cells10020366

2020

54. Szumera-Cieckiewicz A, Poleszczuk J, Paszkiewicz-Kozik E, et al. EZH2 Expression in Follicular Lymphoma Is Variable an Independent from the Progression of Disease Within 24 Months of First Treatment, Anticancer Reasearch, 2020 (40): 6685-97, 10.21873/anticanres.14692

53. Vander Velde R, Yoon N, Marusyk V, et al., Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selectifec pressures, Nature Communications, 2020 (11), doi.org/10.1038/s41467-020-16212-w

52. Szumera-Cieckiewicz A, Poleszczuk J, Kuczkiewicz-Siemion O, et al. PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma, Pathology – Reserarch in Practice, 2020 (216), doi.org/10.1016/j.prp.2020.153096

51. Szumera-Cieckiewicz A, Wojciechowska U, Didkowska J, et al. Population-based epidemiological data of follicular lymphoma in Poland: 15 years of observation, Scientific Reports, 2020 (10), doi.org/10.1038/s41598-020-71579-6

50. Waniewski J, Poleszczuk J, Pietribiasi M, Debowska M, Wojcik-Zaluska A, Zaluska W, Impact of solute exchange between erythrocytes and plasma on hemodialyzer clearance, Biocybernetics and Biomedical Engineering, 2020 (40): 265-276, doi.org/10.1016/j.bbe.2019.04.003

49. Debowska M, Dai L, Wojcik-Zaluska A, Poleszczuk J, et al. Association between Biomarkers of Mineral and Bone Metabolism and Removal of Calcium and Phosphate in Hemodialysis, Blood purification, 2020 (49): 71-8, doi.org/10.1159/000503623

2019

48. Jardim-Perassi BV, Huang S, Dominguez-Viqueira W, Poleszczuk J, et al. Multiparametric MRI and co-registered histology identify tumor habitats in breast cancer mouse models, Cancer Research, 2019 (79), doi.org/10.1158/0008-5472.CAN-19-0213

47. Lopez Alfonso JC, Poleszczuk J, Walker R, Kim S, Pilon-Thomas S, Conejo-Garcia JJ, Soliman H, Czernecki B, Harrison LB, Enderling H, Immunologic consequences of sequencing cancer radiotherapy and surgery, JCO Clinical Cancer Informatics, 2019 (3): 1-16, doi.org/10.1200/CCI.18.00075

46. Stachowska-Pietka J, Poleszczuk J, Teixido-Planas J, et al., Fluid tonicity affects peritoneal characteristics derived by three-pore model, Peritoneal Dialysis International, 2019 (39): 243-251, 10.3747/pdi.2017.00267

45. Stachowska-Pietka J, Poleszczuk J, Flessner MF, et al., Alterations of peritoneal transport characteristics in dialysis patients with ultrafiltration failure: tissue and capillary components, Nephrology Dialysis Transplantation, 2019 (34): 864-70, 10.1093/ndt/gfy313

2018

44. Poleszczuk J, Enderling H, The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity, International Journal of Molecular Sciences, 2018 (19): 3377, doi.org/10.3390/ijms19113377

43. Debowska M, Poleszczuk J, Dabrowski W, et al., Impact of hemodialysis on cardiovascular system assessed by pulse wave analysis, PLOS One, 2018, 10.1371/journal.pone.0206446.

42. Potrebko PS, Keller A, All S, et al., GammaKnife versus VMAT radiosurgery plan quality for many brain metastases, Journal of Applied Clinical Medical Physics, 2018, doi.org/10.1002/acm2.12471

41. Poleszczuk J, Debowska M, Dabrowski W, et al., Patient-specific pulse wave propagation model identifies cardiovascular risk characteristics in hemodialysis patients, PLOS Computational Biology, 2018, doi.org/10.1371/journal.pcbi.1006417

40. Kather JK, Charoentong P, Suarez-Carmona M, …, Poleszczuk J, High-throughput screening of combinatorial immunotherapies with patient-specific in silico models of metastatic colorectal cancer, Cancer Research, 2018, doi.org/10.1158/0008-5472.CAN-18-1126

39. Walker R, Poleszczuk J, Pilon-Thomas S, et al., Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy, Scientific Reports, 2018, doi.org/10.1038/s41598-018-27718-1

38. Potrebko PS, Shridhar R, Biagioli MC, Sensakovic WF, Andl G, Poleszczuk J, Fox TH, SPECT/CT image-based dosimetry for Yttrium-90 radionuclide therapy: Application to treatment response, Journal of Applied Clinical Medical Physics, 2018, doi.org/10.1002/acm2.12400

37. Poleszczuk J, Debowska M, Dabrowski W, et al., Subject-specific pulse wave propagation modeling: Towards enhancement of cardiovascular assessment methods, PLOS One, 2018 (13): e0190972, doi.org/10.1371/journal.pone.0190972

2017

36. Kather JK, Poleszczuk J, Suarez-Carmona M, et al., In silico modeling of immunotherapy and stroma-targeting therapies in human colorectal cancer, Cancer Research, 2017, doi.org/10.1158/0008-5472.CAN-17-2006

35. Forys U, Bielczyk NZ, Piskała K, Płomecka M, and Poleszczuk J, Impact of Time Delay in Perceptual Decision-Making: Neuronal Population Modeling Approach, Complexity, 2017, Article ID 4391587, doi.org/10.1155/2017/4391587

34. Walker R, Poleszczuk J, Mejia J, et al.,Toward early detection of Helicobacter pylori-associated gastric cancer, Gastric Cancer, 2017, doi.org/10.1007/s10120-017-0748-z

33. Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H  and Enderling H, Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival, Breast Cancer Research, 2017 (19): 75, doi.org/10.1186/s13058-017-0870-1

32. Waniewski J, Antosiewicz S, Baczynski S, Poleszczuk J, Pietribiasi M, Lindholm B, Wankowicz Z, Changes of peritoneal transport parameters with time on dialysis: Assessment with sequential peritoneal equilibration test, International Journal of Artificial Organs, 2017 (40): 595 – 601, doi.org/10.5301/ijao.5000622

31. Poleszczuk J, Howard R, Moros EG, Latifi K, Caudell JJ, Enderling H, Predicting patient-specific radiotherapy protocols based on mathematical model choice for Proliferation Saturation Index, Bulletin of Mathematical Biology (2017), doi.org/10.1007/s11538-017-0279-0

30. Walker R, Schoenfeld JD, Pilon-Thomas S, Poleszczuk J and Enderling H, Evaluating the potential for maximized T cell redistribution entropy to improve abscopal responses to radiotherapy, Convergent Science Physical Oncology, 2017 (3): 034001, doi.org/10.1088/2057-1739/aa7269

29.Potrebko P, Fiege J, Biagioli M, Poleszczuk J, Investigating multi-objective fluence and beam orientation IMRT optimization, Physics in Medicine and Biology, 2017 (62): 5228, doi:10.1088/1361-6560/aa7298

2016

28. Poleszczuk J, Johnstone PA, Enderling H, Stratifying prostate cancer patients by relative lymph node involvement: population- and modeling-based study, Cancer Medicine, 2016 (5): 1850-1855, doi:10.1002/cam4.776

27. Poleszczuk J, Debowska M, Wojcik-Zaluska A, Ksiazek A, Zaluska W, Phosphate kinetics in hemodialysis: application of delayed pseudo one-compartment model, Blood Purification, 2016 (42): 177-185, doi:10.1159/000445934

26. Waniewski J, Antosiewicz S, Baczynski D, Poleszczuk J, Pietribiasi M, Lindholm B, Wankowicz Z, Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients, Computational and Mathematical Methods in Medicine, vol. 2016, Article ID 8204294, 10 pages, 2016. doi:10.1155/2016/8204294

25. Poleszczuk J, Macklin P, Enderling H, Agent-Based Modeling of Cancer Stem Cell Driven Solid Tumor Growth, Chapter in Methods in molecular biology (Clifton, N.J.), April 2016.

24. Poleszczuk J, Luddy KA, Prokopiou S, Robetson-Tessi M, Moros E, Fishman M, Djeu JY, Finkelstein SE, Enderling H, Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions, Cancer Research, March 1, 2016 (76): 1009, doi:10.1158/0008-5472.CAN-15-1423

23. Poleszczuk J, Enderling H, Cancer Stem Cell Plasticity as Tumor Growth Promoter and Catalyst of Population Collapse, Stem Cells International, vol. 2016, Article ID 3923527, 12 pages, 2016.doi:10.1155/2016/3923527 .

2015

22. Widel M, Lalik A, Krzywon A, Poleszczuk J, Fujarewicz K, Rzeszowska-Wolny J, The different radiation response and radiation-induced bystander effects in colorectal carcinoma cells differing in p53 status, Mutation Research, 2015 (778):61-70.

21.Prokopiou S, Moros EG, Poleszczuk J, Caudell J, Torres-Roca JF, Latifi K, et al., A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation, Radiation Oncology, 2015 (10):159.

20. Debowska M, Poleszczuk J, Wojcik-Zaluska A, Ksiazek A, Zaluska W, Mathematical modeling of phosphate kinetics during weekly cycle of hemodialysis sessions, Artificial Organs, 2015.

19. Poleszczuk J, Krzywon A, Forys U, Widel M, Connecting radiation-induced bystander effects and senescence to improve radiation response prediction, Radiation Research, 2015 (183):571-577.

18. Poleszczuk J, Hahnfeldt P, Enderling H, Evolution and phenotypic selection of cancer stem cells, PLOS Computational Biology 2015, DOI: 10.1371/journal.pcbi.1004025

17. Poleszczuk J, Hahnfeldt P, Enderling H, Therapeutic implications from sensitivity analysis of tumor angiogenesis models, PLOS One 2015, DOI: 10.1371/journal.pone.0120007

2014

16. Poleszczuk J, Enderling H, A High-Performance Cellular Automaton Model of Tumor Growth with Dynamically Growing Domains, Applied Mathematics 2014 (5): 144-152.

15. Forys U, Poleszczuk J, Liu T, Logistic tumor growth with delay and impulsive treatment, Mathematical Population Studies 2014 (21): 146-158.

14.Poleszczuk J, Piotrowska MJ, Forys U, Optimal protocols for the anti-VEGF tumor treatment, Mathematical Modelling of Natural Phenomena, 2014 (9): 204-215.

13.Waniewski J, Poleszczuk J, Antosiewicz S, et al., Can the three pore model correctly describe peritoneal transport of protein?, ASAIO Journal, 2014 (60): 576-581.

12. Miekisz J, Matuszak M, Poleszczuk J, Stochastic stability in three-player games with time delays, Dynamic Games and Applications, 2014 (4): 489-498.

11. Poleszczuk J, Hahnfeldt P, Enderling H, Biphasic modulation of cancer stem cell driven solid tumour dynamics in response to reactivated replicative senescence, Cell proliferation 2014 (47): 267-276.

2013

10. Piotrowska MJ, Bodnar M, Poleszczuk J, Foryś U, Mathematical modeling of immune reaction against gliomas: Sensitivity analysis and influence of delays, Nonlinear Analysis: Real World Applications 2013 (14): 1601-1620

9. Piotrowska MJ, Foryś U, Bodnar M, Poleszczuk J, A simple model of carcinogenic mutations with time delay and diffusion, Mathematical Biosciences and Engineering 2013 (10): 861-872

8. Poleszczuk J, Mathematical modelling of tumour angiogenesis, Mathematica Applicanda 2013 (41): 1-12

2011

7. Bodnar M, Poleszczuk J, Foryś U, Analysis of biochemical reactions models with delays, Journal of Mathematical Analysis and Applications 2011 (376): 74–83

6. Miękisz J, Poleszczuk J, Bodnar M, Foryś U, Stochastic models of gene expression with delayed degradation, Bulletin of Mathematical Biology 2011 (73): 2231–2247

5. Poleszczuk J, Bodnar M, Foryś U, New approach to modelling of antiangiogenic treatment on the basis of Hahnfeldt et al. model, Mathematical Biosciences and Engineering 2011 (8): 591–603

4. Foryś U, Poleszczuk J, A delay–differential equation model of HIV related cancer–immune system dynamics, Mathematical Biosciences and Engineering 2011 (8): 627–641

3. Foryś U, Bodnar M, Poleszczuk J, Negativity of delayed induced oscillations in a simple linear DDE, Applied Mathematics Letters 2011 (24): 982–986

2. Poleszczuk J, Skrzypczak I, Tumour angiogenesis model with variable vessels’ effectiveness, Applicationes Mathematicae (Warsaw) 2011 (38): 33–49

2009

1.Poleszczuk J, Foryś U, Angiogenesis process with vessel impairment for Gompertzian and logistic type of tumour growth, Applicationes Mathematicae (Warsaw) 2009 (36): 313–331